A genetic variation in APE1 is associated with gastric cancer survival in a Chinese population

Cancer Science

Volumn 102, Issue 7, 2011, Pages 1293-1297

  Zhao, Qinghong ^a   Wang, Wei ^a   Zhang, Zhengdong ^b   Wang, Shizhi ^b   Wang, Meilin ^b   Zhou, Jianwei ^c   Gong, Weida ^d   Tan, Yongfei ^e   Wang, Baolin ^a   Chen, Guoyu ^f  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Yixing Cancer Hospital   (China)

^e YIXING PEOPLE S HOSPITAL   (China)

^f THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE;

ADULT; AGED; APE1 GENE; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CHINESE; DISTANT METASTASIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS;

EID: 80955180943     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01959.x     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228: 449-61.
3. Hewin DF. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998; 85: 874.
4. Peddanna N, Holt S, Verma RS. Genetics of gastric cancer. Anticancer Res 1995; 15: 2055-64.
5. Brennan MF. Current status of surgery for gastric cancer: a review. Gastric Cancer 2005; 8: 64-70.
6. Becker KF, Keller G, Hoefler H. The use of molecular biology in diagnosis and prognosis of gastric cancer. Surg Oncol 2000; 9: 5-11.
7. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005; 162: 925-42.
8. Ide H, Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull 2004; 27: 480-5.
9. Rothwell DG, Hang B, Gorman MA, Freemont PS, Singer B, Hickson ID. Substitution of Asp-210 in HAP1 (APE/Ref-1) eliminates endonuclease activity but stabilises substrate binding. Nucleic Acids Res 2000; 28: 2207-13.
10. Demple B, Herman T, Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci USA 1991; 88: 11450-4.
11. Robson CN, Hickson ID. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res 1991; 19: 5519-23.
12. Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S. Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J 2003; 22: 6299-309.
13. Fuchs S, Philippe J, Corvol P, Pinet F. Implication of Ref-1 in the repression of renin gene transcription by intracellular calcium. J Hypertens 2003; 21: 327-35.
14. Naganuma T, Nakayama T, Sato N et al. Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension. Am J Hypertens 2010; 23: 186-91.
15. Naganuma T, Nakayama T, Sato N et al. Haplotype-based case-control study between human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and cerebral infarction. Clin Biochem 2009; 42: 1493-9.
16. Lu J, Zhang S, Chen D et al. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J 2009; 23: 3459-69.
17. Lo YL, Jou YS, Hsiao CF et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009; 18: 223-9.
18. Wang M, Bai J, Tan Y et al. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer 2010; doi: [Epub ahead of print].
19. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4.
20. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-15.
21. Lee JM, Lee YC, Yang SY et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 2001; 95: 240-6.
22. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
23. Nardone G, Compare D. Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis. Expert Rev Gastroenterol Hepatol 2008; 2: 243-8.